Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3-Avadel Pharmaceuticals plc

10th Nov 2025 12:19

RNS Number : 9056G
Bank of America Merrill Lynch
10 November 2025
 

FORM 8.3 Replacement

 

 

The Form 8.3 AVADEL PHARMACEUTICALS PLC announcement released on 07/11/2025under RNS 7236G has been amended.

 

Amendments are identified with an asterisk (*).

 

 

 

The full amended text is shown below

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

Bank of America Corporation

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

AVADEL PHARMACEUTICALS PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

06/11/2025

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

0.01 ordinary shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

*2,594,342

*2.664%

*748,133

*0.768%

(2) Cash-settled derivatives

406,227

0.417%

1,243,155

1.276%

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0.000%

0

0.000%

Total

*3,000,569

*3.081%

*1,991,288

*2.044%

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Purchase

6

18.71 USD

USD 0.01 common

Purchase

3

18.76 USD

USD 0.01 common

Purchase

7,138

18.7627 USD

USD 0.01 common

Purchase

6

18.79 USD

USD 0.01 common

Purchase

15

18.8 USD

USD 0.01 common

Purchase

6

18.82 USD

USD 0.01 common

Purchase

6

18.83 USD

USD 0.01 common

Purchase

1,600

18.835 USD

USD 0.01 common

Purchase

999

18.835006 USD

USD 0.01 common

Purchase

5

18.84 USD

USD 0.01 common

Purchase

7,956

18.845 USD

USD 0.01 common

Purchase

165

18.845031 USD

USD 0.01 common

Purchase

11

18.845455 USD

USD 0.01 common

Purchase

14,300

18.85 USD

USD 0.01 common

Purchase

2

18.86 USD

USD 0.01 common

Purchase

47

18.88 USD

USD 0.01 common

Purchase

6

18.89 USD

USD 0.01 common

Purchase

6

18.9 USD

USD 0.01 common

Purchase

7

18.91 USD

USD 0.01 common

Purchase

16

18.92 USD

USD 0.01 common

Purchase

144

18.95 USD

USD 0.01 common

Purchase

12

18.96 USD

USD 0.01 common

Purchase

1

18.94 USD

USD 0.01 common

Purchase

3

18.93 USD

USD 0.01 common

Purchase

4

18.97 USD

USD 0.01 common

Purchase

5

18.91 USD

USD 0.01 common

Purchase

5

18.92 USD

USD 0.01 common

Purchase

6

18.98 USD

USD 0.01 common

Purchase

30

18.71 USD

USD 0.01 common

Purchase

816

18.802917 USD

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Sale

2

18.715 USD

USD 0.01 common

Sale

2

18.73 USD

USD 0.01 common

Sale

4

18.74 USD

USD 0.01 common

Sale

40

18.78 USD

USD 0.01 common

Sale

61

18.79 USD

USD 0.01 common

Sale

49

18.8 USD

USD 0.01 common

Sale

18

18.805 USD

USD 0.01 common

Sale

14

18.805715 USD

USD 0.01 common

Sale

127

18.81 USD

USD 0.01 common

Sale

32

18.815 USD

USD 0.01 common

Sale

3

18.816667 USD

USD 0.01 common

Sale

122

18.82 USD

USD 0.01 common

Sale

60

18.83 USD

USD 0.01 common

Sale

26

18.835 USD

USD 0.01 common

Sale

72

18.84 USD

USD 0.01 common

Sale

72

18.845 USD

USD 0.01 common

Sale

3

18.846667 USD

USD 0.01 common

Sale

320

18.85 USD

USD 0.01 common

Sale

48

18.855 USD

USD 0.01 common

Sale

38

18.86 USD

USD 0.01 common

Sale

62

18.87 USD

USD 0.01 common

Sale

8

18.875 USD

USD 0.01 common

Sale

53

18.88 USD

USD 0.01 common

Sale

1,173

18.886599 USD

USD 0.01 common

Sale

6

18.89 USD

USD 0.01 common

Sale

1

18.9 USD

USD 0.01 common

Sale

45

18.91 USD

USD 0.01 common

Sale

136

18.94 USD

USD 0.01 common

Sale

15

18.946667 USD

USD 0.01 common

Sale

218

18.95 USD

USD 0.01 common

Sale

12

18.97 USD

USD 0.01 common

Sale

55

18.98 USD

USD 0.01 common

Sale

1,397

18.76 USD

USD 0.01 common

Sale

900

18.715 USD

USD 0.01 common

Sale

700

18.775 USD

USD 0.01 common

Sale

600

18.77 USD

USD 0.01 common

Sale

335

18.735 USD

USD 0.01 common

Sale

216

18.73 USD

USD 0.01 common

Sale

100

18.78 USD

USD 0.01 common

Sale

100

18.725 USD

USD 0.01 common

Sale

100

18.72 USD

USD 0.01 common

Sale

100

18.75 USD

USD 0.01 common

Sale

2

18.97 USD

USD 0.01 common

Sale

1

18.93 USD

USD 0.01 common

Sale

1

18.92 USD

USD 0.01 common

Sale

1

18.95 USD

USD 0.01 common

Sale

1

18.96 USD

 

 

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

 USD

USD 0.01 common

Swaps

Reducing a short position

870

18.886400 USD

USD 0.01 common

Swaps

Reducing a short position

8

18.939800 USD

USD 0.01 common

Swaps

Reducing a short position

11

18.886400 USD

USD 0.01 common

Swaps

Opening a Short position

7,138

18.764200 USD

USD 0.01 common

Swaps

Reducing a long position

816

18.803217 USD

USD 0.01 common

Swaps

Reducing a long position

30

18.710500 USD

USD 0.01 common

Swaps

Increasing a short position

11

18.846100 USD

USD 0.01 common

Swaps

Opening a long position

292

18.886400 USD

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

N/A

N/A

N/A

N/A

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

No

 

Date of disclosure

*10/11/2025

Contact name

Kamil Dziedzic

Telephone number

+353 86 168 4821

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPLBLFFEFLFFBD
FTSE 100 Latest
Value9,870.33
Change83.18